Depakote - 49999-941-30 - (Divalproex Sodium)

Alphabetical Index


Drug Information of Depakote

Product NDC: 49999-941
Proprietary Name: Depakote
Non Proprietary Name: Divalproex Sodium
Active Ingredient(s): 250    mg/1 & nbsp;   Divalproex Sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Depakote

Product NDC: 49999-941
Labeler Name: Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018723
Marketing Category: NDA
Start Marketing Date: 20111114

Package Information of Depakote

Package NDC: 49999-941-30
Package Description: 30 TABLET, DELAYED RELEASE in 1 BOTTLE (49999-941-30)

NDC Information of Depakote

NDC Code 49999-941-30
Proprietary Name Depakote
Package Description 30 TABLET, DELAYED RELEASE in 1 BOTTLE (49999-941-30)
Product NDC 49999-941
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Divalproex Sodium
Dosage Form Name TABLET, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20111114
Marketing Category Name NDA
Labeler Name Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC
Substance Name DIVALPROEX SODIUM
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of Depakote


General Information